Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News China SXT Pharmaceuticals Inc. SXTC

China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:SXTC)

Fundamentals Snapshot (NDAQ:SXTC)

Current News (NDAQ:SXTC)

China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

GlobeNewswire May 18, 2022

China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million

GlobeNewswire March 14, 2022

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).

Accesswire January 20, 2022

China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment

GlobeNewswire January 20, 2022

China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

GlobeNewswire January 18, 2022

China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

GlobeNewswire January 14, 2022

China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin

PR Newswire January 14, 2022

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

PR Newswire December 16, 2021

China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection

PR Newswire October 18, 2021

Opinion & Analysis (NDAQ:SXTC)

No current opinion is available.

Bullboard Posts (NDAQ:SXTC)

SXTC ....when will the "White Knight" show up ; )

sooner than later ?
Iseneschal - March 30, 2022

SXTC.....Bottom formation....bouncing

Still on watch  No Position
Iseneschal - March 30, 2022

SXTC ...failed to hold support ...stopped out

Cheers !
Iseneschal - March 29, 2022

SXTC .....targets ahead.. 37 ....40 .....44...then N>H.O.D

Cheers and GL
Iseneschal - March 29, 2022

SXTC .... Early.a.m runner in PB mode

Has to hold support at $0.325 and rally ....if not ....it will be toast !
Iseneschal - March 29, 2022

it's a buy today for me after hours

it was on my watchlist and it was breaking out to the upside on my charts,so glta.
coolfooldumbguy - February 27, 2020